Astellas Pharma Inc: all 983 studies

Page 1 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.

• A Long-term Follow-up Study in Male Participants With X-linked Myotubular Myopathy Treated With ASP2957Not yet recruitingNCT07876804Phase 1/2
• Zolbetuximab and Other Cancer Treatments in People With Advanced Gastric or GEJ Cancer in Clinical Practice (RADIANCE)Not yet recruitingNCT07858500
• A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric CancerNot yet recruitingNCT07829757Phase 4
• A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through MenopauseNot yet recruitingNCT07829653Phase 3
• A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate CancerRecruitingNCT07783282Phase 1
• A Study to Learn How ASP3082 is Processed in Healthy MenRecruitingNCT07773129Phase 1
• A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve DamageRecruitingNCT07770685Phase 1/2
• A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye ConditionsRecruitingNCT07734064Phase 1
• A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid TumorsRecruitingNCT07730021Phase 1/2
• A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric CancerRecruitingNCT07673887Phase 3
• A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate)Not yet recruitingNCT07619105
• A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeRecruitingNCT07602530
• Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)RecruitingNCT07566156Phase 3
• A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationRecruitingNCT07566052Phase 3
• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsRecruitingNCT07488676Phase 1/2
• A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderRecruitingNCT07475806Phase 2
• A Study to Learn How Stargardt-type Eye Conditions Progress in Children and AdultsRecruitingNCT07425574
• A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerRecruitingNCT07409272Phase 3
• A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate CancerRecruitingNCT07339267Phase 1
• A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a StrokeRecruitingNCT07318714Phase 1/2
• A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsRecruitingNCT07287995Phase 1/2
• A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07140016Phase 1
• A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsRecruitingNCT07094204Phase 1
• Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need VentilatorsRecruitingNCT07052929Phase 1/2
• A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerRecruitingNCT07024615Phase 1
• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerRecruitingNCT07005154Phase 2
• Akyva First In HumanRecruitingNCT06956209Not applicable
• A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.RecruitingNCT06902545
• A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingNCT06901531Phase 3
• A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial CancerRecruitingNCT06862219Phase 4
• A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle ConditionRecruitingNCT06581146
• Early Access Program for ZolbetuximabAvailableNCT06048081
• A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV InjectionRecruitingNCT06011954
• Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruitingNCT05997615Phase 1
• A Study of ASP1002 in Adults for Treatment of Solid TumorsRecruitingNCT05719558Phase 1
• A Study of ASP3082 in Adults With Advanced Solid TumorsRecruitingNCT05382559Phase 1
• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerRecruitingNCT05365581Phase 1
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerRecruitingNCT04729114Phase 1
• A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationRecruitingNCT03178149Phase 1
• A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell TherapyEnrolling by invitationNCT03167203Phase 1/2
• A Study to Compare the Use of Diabetes Treatment Support System (BAP0527 and Blood Glucose Meter) in Addition to Daily Practice and Treatment With Daily Practice and Treatment Alone in Patients With Type 2 Diabetes MellitusCompletedNCT06156696Results posted
• A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During SurgeryCompletedNCT05754333Phase 3Results posted
• Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMDTerminatedNCT05571267Phase 2Results posted
• Avacincaptad Pegol Open-Label Extension for Patients With Geographic AtrophyCompletedNCT05536297Phase 3Results posted
• A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During SurgeryTerminatedNCT05457842Phase 2Results posted
• Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot FlashesCompletedNCT05419908Phase 2Results posted
• A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor TherapyCompletedNCT04995419Phase 2Results posted
• Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression ParticipantsTerminatedNCT04939701Phase 1/2Results posted
• Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 AntigenCompletedNCT04837196Phase 1/2Results posted
• A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)TerminatedNCT04641975Phase 3Results posted
• A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial MyopathyTerminatedNCT04641962Phase 2Results posted
• A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive BladderCompletedNCT04562090Phase 4Results posted
• A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese ParticipantsCompletedNCT04501640Phase 4Results posted
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using ParticipantsCompletedNCT04448561Phase 1Results posted
• A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use DisorderCompletedNCT04447287Phase 1Results posted
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)CompletedNCT04435366Phase 3Results posted
• A Study to Assess ASP0598 Otic Solution Following Topical Application in the Ear in Subjects With Chronic Tympanic Membrane Perforation (CTMP)TerminatedNCT04305184Phase 1/2Results posted
• A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)TerminatedNCT04240002Phase 1/2Results posted
• A Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal SurgeryCompletedNCT04238481Phase 2Results posted
• A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Active, not recruitingNCT04225117Phase 2Results posted
• Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial CancerActive, not recruitingNCT04223856Phase 3Results posted
• A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)CompletedNCT04079296Phase 1/2Results posted
• An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Active, not recruitingNCT04076059Phase 3Results posted
• A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through MenopauseCompletedNCT04003389Phase 3Results posted
• A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through MenopauseCompletedNCT04003155Phase 3Results posted
• A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2CompletedNCT04003142Phase 3Results posted
• Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve SurgeryCompletedNCT03941483Phase 2Results posted
• A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric ParticipantsCompletedNCT03816176Phase 2Results posted
• A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell TumorsCompletedNCT03760081Phase 2Results posted
• A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)CompletedNCT03730012Phase 1/2Results posted
• A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).Active, not recruitingNCT03653507Phase 3Results posted
• A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based ChemotherapyCompletedNCT03641560Phase 4Results posted
• A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic MedicationCompletedNCT03557931Phase 2Results posted
• A Phase 2 Clinical Trial Examining the Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5 and Vehicle ControlCompletedNCT03528369Phase 2Results posted
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.Active, not recruitingNCT03504397Phase 3Results posted
• A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)CompletedNCT03474107Phase 3Results posted
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)CompletedNCT03364153Phase 2Results posted
• ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)CompletedNCT03362190Phase 2Results posted
• A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder CancerCompletedNCT03219333Phase 2Results posted
• A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM)Active, not recruitingNCT03199469Phase 2/3Results posted
• A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)CompletedNCT03192176Phase 2Results posted
• A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) MutationCompletedNCT03182244Phase 3Results posted
• Osteoarthritis Knee Pain Relief Study of 0.25% 920-CGS-200CompletedNCT03124407Phase 4Results posted
• A Dose-finding Study of ASP4070CompletedNCT03101267Phase 2Results posted
• A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With FibromyalgiaCompletedNCT03092726Phase 2Results posted
• A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With FibromyalgiaCompletedNCT03056690Phase 2Results posted
• A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome PatientsCompletedNCT03053427Phase 4Results posted
• A Study of ELIGARD® in Hormone-dependent Prostate Cancer PatientsCompletedNCT03035032Phase 4Results posted
• A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)CompletedNCT02997202Phase 3Results posted
• A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete RemissionCompletedNCT02927262Phase 2Results posted
• Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant RecipientsCompletedNCT02921789Phase 2Results posted
• Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate CancerCompletedNCT02918968Phase 4Results posted
• A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active SurveillanceCompletedNCT02799745Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT02757768Phase 4Results posted
• A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard ChemotherapyCompletedNCT02752035Phase 3Results posted
• Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor OveractivityCompletedNCT02751931Phase 3Results posted
• To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant RecipientsCompletedNCT02723591Phase 4Results posted
• Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular DegenerationCompletedNCT02686658Phase 2/3Results posted
• A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)CompletedNCT02677896Phase 3Results posted
• A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT02662582Phase 2Results posted

← Astellas Pharma Inc overview and focus areas